StemoniX wins MedTech Innovator’s MOST DISRUPTIVE MEDy Award as the Most Transformative Company! Read more here!
Empowering the discovery of new medicines to treat challenging diseases
StemoniX seeks to transform conventional drug development via iPSC-derived, ready-to-use assay plates containing functional microOrgans®, including
electrically active neurons (microBrain®) and contracting cardiomyocytes (microHeart®).
Structure Leads to Improved Cell-Based Assay Outcomes
StemoniX provides products and services for drug discovery and development. We structure human iPSC-derived cells into physiologically relevant microtissues with accelerated cell maturity that mimic the native organ tissue. Predictive, accurate, and consistent, our in vitro human cell-based products enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow.
Products and Services